GSA Capital Partners’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,268
| Closed | -$195K | – | 1448 |
|
|
2023
Q2 | $195K | Sell |
12,268
-75,700
| -86% | -$1.2M | 0.02% | 1278 |
|
|
2023
Q1 | $631K | Buy |
87,968
+4,885
| +6% | +$35K | 0.06% | 569 |
|
|
2022
Q4 | $481K | Buy |
83,083
+75,175
| +951% | +$435K | 0.06% | 621 |
|
|
2022
Q3 | $75K | Buy |
+7,908
| New | +$75K | 0.01% | 1393 |
|
|
2022
Q2 | – | Sell |
-39,559
| Closed | -$518K | – | 1350 |
|
|
2022
Q1 | $518K | Sell |
39,559
-12,669
| -24% | -$166K | 0.07% | 506 |
|
|
2021
Q4 | $919K | Buy |
+52,228
| New | +$919K | 0.12% | 243 |
|
|
2020
Q4 | – | Sell |
-1,166
| Closed | -$120K | – | 1160 |
|
|
2020
Q3 | $120K | Buy |
+1,166
| New | +$120K | 0.02% | 1107 |
|
|
2020
Q1 | – | Sell |
-1,628
| Closed | -$188K | – | 1010 |
|
|
2019
Q4 | $188K | Buy |
+1,628
| New | +$188K | 0.02% | 1272 |
|
|
2018
Q4 | – | Sell |
-1,480
| Closed | -$90K | – | 1305 |
|
|
2018
Q3 | $90K | Buy |
+1,480
| New | +$90K | 0.01% | 1565 |
|